Innovasjonseksempler

Researchers at the University of Oslo and Oslo University Hospital work towards advancing the field of organ-on-chip and organoid technology ¨C microphysiological systems ¨C to develop better models to represent human physiology and metabolism as tools for drug development and personalised medicine, and as a strategy for reducing animal experimentation. They are in the middle of working out how to take their technology to the market.

Currently farmers are dependent on large companies to buy nitrogen-enriched fertilisers. Researchers at UiO are developing a new method that may allow farmers to produce emission-free fertilisers locally at a smaller scale. This will be especially useful for farmers in third world countries.

Data leakage and theft has been a recurring problem throughout the world. This is a significant issue particularly with sensitive data like personal health data. Nikolai Opdan and his team are in the process of developing Topositus which helps to hinder this from happening.

Preterm labor is a significant risk to both mother and child. What if there was a test that could detect and measure the risk of preterm labor for women before and during pregnancy and safeguard the lives of both the mother and child?

Older adults in home healthcare often need seamless care across services. They are negatively affected by how dental care is organised in Norway. Vibeke Ansteinsson and her team are working closely with municipalities and several companies aimed at solving this problem by developing a digital platform.

Curiosity and an entrepreneurial innovative mindset brought two UiO scientists together. Through their startup they aim to create a rapid and compact point-of-care molecular diagnostic device to address the need for increased accessibility and efficiency for detection of diseases in pets.

A newly discovered biomarker may be the key for earlier and significantly improved detection of solid cancer. Carmen Herrera, a researcher from Department of Biosciences, leads the research and development of a new blood-based test.

A cross-disciplinary collaboration between research teams from developmental biology, analytical chemistry, microfluidics, physics and computer science fields will hopefully result in a miniaturised analytical tool for mini organs in the organ-on-a-chip research. This can be a revolutionary tool in the development of new drugs that reduces the need for animal testing.